Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and efficacy of AMG 706 in patients with
gastrointestinal stromal tumor that have not been controlled while taking imatinib mesylate.